Lydia Rabinowich
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 246 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,428 and has fallen 98.4% since, to $24 in 2024.
Across 246 payments — averaging $18.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$835
- Teva Pharmaceuticals USA, Inc.$471
- Abbott$375
- EMD Serono, Inc.$290
- AstraZeneca$284
- Novartis$267
- plus $2K from 29 others
What the payments were for
- Speaking & faculty fees$231%
- Food & beverage$4,44899%
- Education$261%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 41 | $835 |
| Teva Pharmaceuticals USA, Inc. | 25 | $471 |
| Abbott | 12 | $375 |
| EMD Serono, Inc. | 19 | $290 |
| AstraZeneca | 23 | $284 |
| Novartis | 14 | $267 |
| Acadia Pharmaceuticals Inc | 20 | $240 |
| Biogen | 13 | $239 |
| Amgen(2 entities) | 9 | $195 |
| MDD US Operations, LLC | 11 | $191 |
| Sanofi | 7 | $141 |
| Pfizer | 5 | $108 |
| Kyowa Kirin, Inc. | 6 | $106 |
| Adamas Pharmaceuticals, Inc. | 6 | $98 |
| Biohaven Pharmaceuticals, Inc. | 5 | $96 |
| Vertical Pharmaceuticals, LLC | 3 | $63 |
| CSL Behring | 2 | $47 |
| Johnson & Johnson | 3 | $45 |
| Amneal Pharmaceuticals LLC | 2 | $42 |
| Medtronic | 2 | $40 |
| UCB, Inc. | 2 | $39 |
| GE HealthCare | 2 | $35 |
| Bausch Health US, LLC | 2 | $33 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Acorda Therapeutics, Inc | 1 | $23 |
| Sunovion Pharmaceuticals Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
| Catalyst Pharmaceuticals, Inc. | 1 | $17 |
| Grifols USA, LLC | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Akcea Therapeutics, Inc. | 1 | $14 |
| Avion Pharmaceuticals | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY$138
How this compares
$4,497 in reported general payments places this provider in the 70th percentile of 1,623 neurology providers in New York.
Other neurology in Bronx
- Richard LiptonBronx$753K
- Michael ThorpyBronx$232K
- Rene ElkinBronx$186K
- Idan SharonBrooklyn$2.1M
- Allan PerelStaten Island$1.7M
- Nicolas SaikaliAmherst$1.5M
- David KreitzmanCommack$1.5M
- Charles ArgoffAlbany$1.2M
- Stephen KriegerNew York$1.1M
- Robert FeketeHawthorne$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.